News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Burow Kristina
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2023 |
4
| ARCH Venture Fund XI, L.P. (10% Owner) has filed a Form 4 on DA32 Life Science Tech Acquisition Corp.|
Txns:
| Disposed of 1,600,000 shares
@ $0 |
|
| 06/09/2023 |
4
| Burow Kristina (Director) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 35,000 options to buy
@ $1.26, valued at
$44.1k
|
|
| 06/08/2023 |
4
| Burow Kristina (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 16,532 options to buy
@ $34.33, valued at
$567.5k
|
|
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2022 |
4
| Burow Kristina (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 10,391 options to buy
@ $55.58, valued at
$577.5k
|
|
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Burow Kristina (Director) has filed a Form 4 on Scholar Rock Holding Corp|
Txns:
| Granted 28,000 options to buy
@ $4.75, valued at
$133k
|
|
| 08/09/2021 |
4
| ARCH Venture Fund XI, L.P. (10% Owner) has filed a Form 4 on DA32 Life Science Tech Acquisition Corp.|
Txns:
| Disposed of 701,250 options to buy
@ $0 |
|
| 08/03/2021 |
4
| ARCH Venture Fund XI, L.P. (10% Owner) has filed a Form 4 on DA32 Life Science Tech Acquisition Corp.|
Txns:
| Bought 1,600,000 shares
@ $10, valued at
$16M
Acquired 650,000 shares
@ $10, valued at
$6.5M
|
|
| 07/20/2021 |
4
| ARCH Venture Partners X, LLC (10% Owner) has filed a Form 4 on Erasca, Inc.|
Txns:
| Converted 5,527,777 shares
@ $0
Converted 2,100,000 preferred shares
@ $0
Converted 3,400,000 preferred shares
@ $0
Converted 1,133,333 preferred shares
@ $0 |
|
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2021 |
4
| Burow Kristina (Director) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 25,000 options to buy
@ $4.18, valued at
$104.5k
|
|
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Burow Kristina (Director) has filed a Form 4 on Scholar Rock Holding Corp|
Txns:
| Granted 7,800 options to buy
@ $26.78, valued at
$208.9k
|
|
| 05/25/2021 |
4
| Burow Kristina (Director) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Granted 16,500 options to buy
@ $4.07, valued at
$67.2k
|
|
| 04/02/2021 |
4
| Burow Kristina (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Disposed of 200,000 shares
@ $0
Disposed of 200,000 shares
@ $0
Acquired 2,011 shares
@ $0 |
|
| 03/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2020 |
4
| Burow Kristina (Director) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 25,000 options to buy
@ $9.14, valued at
$228.5k
|
|
| 06/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2020 |
4
| Burow Kristina (Director) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Granted 28,888 options to buy
@ $37.06, valued at
$1.1M
|
|
| 02/11/2020 |
4
| Burow Kristina (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Converted 4,121,520 shares
@ $0
Converted 4,121,519 shares
@ $0
Converted 1,338,000 preferred shares
@ $0
Converted 1,338,000 preferred shares
@ $0
Converted 2,750,336 preferred shares
@ $0
Converted 2,750,335 preferred shares
@ $0
Converted 33,184 preferred shares
@ $0
Converted 33,184 preferred shares
@ $0 |
|
| 10/18/2019 |
4
| Burow Kristina (Director) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Converted 11,666,665 shares
@ $0
Converted 15,555,554 shares
@ $0
Bought 1,000,000 shares
@ $20, valued at
$20M
Converted 11,111,110 convertible preferred
@ $0
Converted 13,333,332 convertible preferred
@ $0
Converted 555,555 convertible preferred
@ $0
Converted 2,222,222 convertible preferred
@ $0 |
|
| 06/24/2019 |
4
| Burow Kristina (Director) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 25,000 options to buy
@ $9, valued at
$225k
|
|
| 06/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2019 |
4
| Burow Kristina (10% Owner) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.22, valued at
$30.5k
|
|
| 05/23/2019 |
4
| Burow Kristina (10% Owner) has filed a Form 4 on Scholar Rock Holding Corp|
Txns:
| Granted 10,158 options to buy
@ $21.21, valued at
$215.5k
|
|
|
|
|